1. Home
  2. TARS vs UTI Comparison

TARS vs UTI Comparison

Compare TARS & UTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TARS
  • UTI
  • Stock Information
  • Founded
  • TARS 2016
  • UTI 1965
  • Country
  • TARS United States
  • UTI United States
  • Employees
  • TARS N/A
  • UTI N/A
  • Industry
  • TARS Medicinal Chemicals and Botanical Products
  • UTI Other Consumer Services
  • Sector
  • TARS Health Care
  • UTI Real Estate
  • Exchange
  • TARS Nasdaq
  • UTI Nasdaq
  • Market Cap
  • TARS 1.7B
  • UTI 1.4B
  • IPO Year
  • TARS 2020
  • UTI 2003
  • Fundamental
  • Price
  • TARS $69.09
  • UTI $30.10
  • Analyst Decision
  • TARS Strong Buy
  • UTI Strong Buy
  • Analyst Count
  • TARS 7
  • UTI 6
  • Target Price
  • TARS $67.14
  • UTI $34.83
  • AVG Volume (30 Days)
  • TARS 737.2K
  • UTI 806.4K
  • Earning Date
  • TARS 11-12-2025
  • UTI 11-19-2025
  • Dividend Yield
  • TARS N/A
  • UTI N/A
  • EPS Growth
  • TARS N/A
  • UTI 129.25
  • EPS
  • TARS N/A
  • UTI 1.14
  • Revenue
  • TARS $295,521,000.00
  • UTI $809,532,000.00
  • Revenue This Year
  • TARS $137.28
  • UTI $14.75
  • Revenue Next Year
  • TARS $42.84
  • UTI $8.30
  • P/E Ratio
  • TARS N/A
  • UTI $26.35
  • Revenue Growth
  • TARS 254.45
  • UTI 14.56
  • 52 Week Low
  • TARS $32.91
  • UTI $15.14
  • 52 Week High
  • TARS $69.49
  • UTI $36.32
  • Technical
  • Relative Strength Index (RSI)
  • TARS 77.06
  • UTI 51.01
  • Support Level
  • TARS $56.25
  • UTI $30.99
  • Resistance Level
  • TARS $59.78
  • UTI $32.17
  • Average True Range (ATR)
  • TARS 2.58
  • UTI 1.01
  • MACD
  • TARS 1.15
  • UTI 0.08
  • Stochastic Oscillator
  • TARS 97.60
  • UTI 40.84

About TARS Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.

About UTI Universal Technical Institute Inc

Universal Technical Institute Inc is an educational institution. It provides undergraduate degree, as well as certificate programs for technicians in the automotive, diesel, collision repair, motorcycle and marine fields. The company's reportable segment which includes Universal Technical Institute (UTI) and Concorde Career Colleges, Corporate. Majority of the revenue is generated from UTI segment which provides different kinds of degree and non-degree transportation and skilled trades technical training programs under brands such as Universal Technical Institute, Motorcycle Mechanics Institute, Marine Mechanics Institute and others. It also provides dealer technician training or instructor staffing services to manufacturers.

Share on Social Networks: